Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OCI Management
Seoul, South Korea
- Ownership
- Private
- Employees
- ~3850
- Development stage
- Other
01
Overview
OCI Holdings is a South Korean conglomerate that has strategically expanded into the life sciences and biotechnology sectors as a core future growth engine. Since launching its bio business in 2018, the company has pursued an "Acquisition & Development" (A&D) strategy, acquiring a controlling stake in Bukwang Pharmaceutical and investing in various global biotech innovators. Its healthcare portfolio focuses on next-generation cancer diagnostics and therapeutics, including multi-specific recombinant proteins and nanoparticle-based drug delivery systems. OCI Holdings operates through strategic partnerships and a joint management structure with its pharmaceutical subsidiaries to drive innovation in the global oncology market.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeMonoclonal antibodyCell therapyCAR-T cell therapyRecombinant proteinNanoparticle
- Industry
- Biotech
02
Partnerships
Panolos BioscienceSN BioScienceNucleixAdicet Bio
Beyond the preview
Go deeper on OCI Management.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OCI Management.